Getinge AB (GETI B)

Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions.

If you are interested in GETI B stock information, you might also be interested in competitors like NYSE:EW.

The market capitalization of Getinge AB is currently at kr64.39 B. This places it among the high capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 2.73.

With one share of Getinge AB investors achieved a dividend of kr4.02. This results in a very low dividend yield of 1.70%. In the last 14 years, the annual dividend has risen constantly.

For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.43. The price of the stock OM:GETI B is therefore subject to moderate fluctuations in relation to the overall market.

20.18% of GETI B Stocks is owned by insiders.

For Wall Street analysts, a price target of kr349.27 is currently considered realistic.

OM:GETI B has a 52 week range of kr181.20 - kr431.60 and is currently trading around kr236.40.

The low short sale ratio indicated that the value might increase in the foreseeable future.